North America Proteomics Market Report and Forecast 2025-2034

North America Proteomics Market Outlook

The North America proteomics market size was valued at USD 14.92 billion in 2024. The market is further projected to grow at a CAGR of 11.60% between 2025 and 2034, reaching a value of USD 40.88 billion by 2034.

Key Takeaways

• Several analytical tools for studying the proteome are developed and continue to evolve rapidly.

• Proteomics can help the healthcare sector provide precision medicine for patients.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

According to the North America proteomics market analysis, advances in the speed and sensitivity of mass spectrometers, and the development of new methods for sample preparation, data interrogation, and analysis are advancing high-throughput proteomics (HTP). HTP refers to the use of automated and high-capacity analytical techniques for large-scale protein analyses, including protein identification, quantification, and characterisation.

As per the North America proteomics market report, proteomics helps in early disease diagnosis and prognosis as well as in monitoring disease development. By studying proteins at the cellular level, proteomics helps healthcare providers to understand, measure, and track patient health risks in real-time and holistically. Proteomics can facilitate precision medicine for patients, providing them with optimum care when required to achieve optimal health outcomes. For instance, a proteomic test can reveal answers to clinical questions that allow the healthcare sector to efficiently predict, monitor, and prevent the worsening of diseases. This is expected to ultimately help the medical sector treat at-risk patients sooner and before the occurrence of a major health event.  

As proteomics technology continues to advance, the tools can be used to map more proteins, providing the healthcare sector with the most complete view of all the proteins in the human body. This will provide them with informative data on a patient’s current and future health and facilitate the most precise prevention and treatment.

Market Segmentation

North America Proteomics Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments.

Market Breakup by Instrumentation Technology

• Spectroscopy

• Chromatography

• Electrophoresis

• Protein Microarrays

• X-Ray Crystallography

• Others

Market Breakup by Reagent

• Immunoassay Reagents

• Spectroscopy Reagents

• Chromatography Reagents

• Protein Microarray Reagents

• X-Ray Crystallography Reagents

• Others

Market Breakup by Application

• Clinical Diagnostics

• Drug Discovery and Development

• Others

Market Breakup by Country

• United States of America

• Canada

Competitive Landscape

The key players in the proteomics market in North America are advancing the proteomics technology to help the healthcare sector provide efficient treatment to patients.

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc.

• Thermo Fisher Scientific Inc.

• Dotmatics

• Merck KGaA

• Bruker Corporation

• Promega Corporation

• Waters Corporation

• Creative Proteomics

• Seer, Inc.

• Others

Key Highlights of the Report

North America Proteomics Market Report Snapshots

North America Proteomics Market Size

North America Proteomics Companies